SID 2026Abstract 0460
Long-term laboratory trends in patients with moderate-to-severe atopic dermatitis treated with upadacitinib
140-week results from measure up 1 and 2
Cotter D, Shahriari M, Dasilva DR, Domingues E, Narla S, Kirchhof M, Goldberg R, Oza M, Dilley D, Grada A, Irvine A
SID Annual Meeting 2026Chicago, 13–16 May 2026 · published in JID 21 Jul 2026
Topics: Atopic dermatitis & eczema
Abstract
The abstract’s text is on the JID website.
DOI 10.1016/j.jid.2026.06.491 · Not in PubMed: details from Crossref